ABILIFY TABLET
Total Payments
$16,152
Transactions
116
Doctors
60
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2018 | $66.64 | 6 | 6 |
| 2017 | $16,085 | 110 | 54 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $10,521 | 35 | 65.1% |
| Food and Beverage | $2,975 | 78 | 18.4% |
| Unspecified | $2,622 | 1 | 16.2% |
| Education | $33.12 | 2 | 0.2% |
Payments by Type
General
$13,529
115 transactions
Research
$2,622
1 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| STUDY EVALUATING THE SAFETY AND EFFICACY OF FIXED-DOSE ONCE-DAILY ORAL ARIPIPRAZOLE IN CHILDREN AND ADOLESCENTS WITH TOURETTE'S DISORDER31-12-293 | Otsuka Pharmaceutical Development & Commercialization, Inc. | $2,622 | 1 |
Top Doctors Receiving Payments for ABILIFY TABLET — Page 2
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Pediatrics | Brooklyn, NY | $20.67 | 1 |
| , M.D | Specialist | Frisco, TX | $20.28 | 2 |
| , MD | Psychiatry | Northridge, CA | $19.98 | 1 |
| , M.D | Psychiatry | Monterey, CA | $19.98 | 1 |
| , MD | Psychiatry | San Jose, CA | $19.44 | 1 |
| Saul Wasserman | — | San Jose, CA | $19.44 | 1 |
| , M.D | Psychiatry | Philadelphia, PA | $19.33 | 1 |
| , M.D | Psychiatry | Bridgeton, MO | $18.51 | 1 |
| , MD | Psychiatry | Arlington, VA | $18.04 | 1 |
| , MD | Psychiatry | Columbus, GA | $17.84 | 1 |
| , D.O | Psychiatry | Columbus, GA | $17.84 | 1 |
| , MD | Psychiatry | Goshen, IN | $17.68 | 1 |
| , M.D | Psychiatry | Saint Charles, MO | $17.28 | 1 |
| David Sall | — | Jacksonville, FL | $16.56 | 1 |
| , D.O | Neuromusculoskeletal Medicine & OMM | Grand Rapids, MI | $16.56 | 1 |
| , D.O | Psychiatry | Goshen, IN | $16.45 | 1 |
| , M.D | Psychiatry | Tuscaloosa, AL | $15.68 | 1 |
| , M.D | Psychiatry | Tuscaloosa, AL | $15.68 | 1 |
| , M.D | Psychiatry | Harlan, KY | $14.34 | 1 |
| , MD | Psychiatry | Chicago, IL | $14.22 | 1 |
| , MD | Psychiatry | Bensalem, PA | $14.08 | 1 |
| , MD | Psychiatry | Waterbury, CT | $13.84 | 1 |
| , M.D | Psychiatry | Brookfield, CT | $13.84 | 1 |
| , M.D | Psychiatry | Cincinnati, OH | $13.62 | 1 |
| , M.D | Psychiatry | Lawrenceburg, IN | $12.79 | 1 |
Ad
Manufacturing Companies
Product Information
- Type Drug
- Total Payments $16,152
- Total Doctors 60
- Transactions 116
About ABILIFY TABLET
ABILIFY TABLET is a drug associated with $16,152 in payments to 60 healthcare providers, recorded across 116 transactions in the CMS Open Payments database. The primary manufacturer is Otsuka Pharmaceutical Development & Commercialization, Inc..
Payment data is available from 2017 to 2018. In 2018, $66.64 was paid across 6 transactions to 6 doctors.
The most common payment nature for ABILIFY TABLET is "Travel and Lodging" ($10,521, 65.1% of total).
ABILIFY TABLET is associated with 1 research study, including "STUDY EVALUATING THE SAFETY AND EFFICACY OF FIXED-DOSE ONCE-DAILY ORAL ARIPIPRAZOLE IN CHILDREN AND ADOLESCENTS WITH TOURETTE'S DISORDER31-12-293" ($2,622).